Search

everythinglearnresearchcommunity

for

Search:↓

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The report shows a young man with Hutchinson-Gilford Progeria Syndrome had typical and additional eye problems related to the disease.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Oral isotretinoin effectively stabilizes frontal fibrosing alopecia.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Severe itching from shingles can cause hair loss due to rubbing.

Trichoscopy helps tell apart hair loss due to alopecia areata from trichotillomania in eyebrows.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

The girl has both monilethrix and Type 1 diabetes, but no link between the two conditions is known.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Lichen planopilaris should be considered in diagnosing scarring hair loss in Black women.

Oral tofacitinib successfully treated total body hair loss in one patient.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.